US approves 1st drug developed to prevent chronic migraines

By LINDA A. JOHNSON
TRENTON, N.J. (AP) — U.S. regulators Thursday approved the first drug designed to prevent chronic migraines. The Food and Drug Administration’s action clears the monthly shot Aimovig (AIM’-oh-vig) for sale. It’s the first in a new class of long-acting drugs for preventing migraines. Three other shots are expected to [READ MORE HERE]

Source: Seattle Times

Aggregated News

Aggregated news from around the world, brought to you in a single source for convenience. These snippets of news include a link to the full article. Please peruse our other editorial and original content, as well. 

Leave a Reply

Be the First to Comment!

avatar
  Subscribe  
Notify of